TRIPLICATE PRESCRIPTION PROGRAM (TPP)
REDUCING PRESCRIPTION DRUG MISUSE AND ABUSE
Established in 1986, the Triplicate Prescription program (TPP) monitors the use of certain drugs prone to misuse and abuse in Alberta. TPP is administered by CPSA in collaboration with partner organizations.
TPP collects prescribing and dispensing data for listed drugs.
When the data meet certain criteria, physicians and others involved in the care of the patient are alerted, provided with information and directed to resources that can support them in providing safe care.
Triplicate Prescription Program Guide
TPP GuideProgram Information for Prescribers
Registering as a prescriber with TPP
- Prescribers must register with TPP to prescribe any medication on the TPP medication list.
- Medical Residents must obtain approval from their program director prior to registering with TPP.
Re-ordering Triplicate pads
Email TPPinfo@cpsa.ab.ca or contact 1 800 561 3899 ext 4939. Include the following information with your request:
- Your registration number
- Your clinic’s complete address including postal code
- Phone number that is to be printed on the pads
- Complete address for shipping, if different.
Lost or stolen TPP forms
If your TPP pad or any of the forms are missing or stolen, you must contact the police and notify CPSA immediately. The prescriber should provide the following information to CPSA:
- Date of Theft or loss
- Triplicate Prescription number of the missing form(s) or pad(s)
- Name of the last patient prescribed a triplicate prescription
- The police file number and investigating constable’s name and phone number.
Program Information for Pharmacists
List of Stolen and Missing Triplicates
Pharmacists looking for the list of stolen or missing triplicates can access the list through the Alberta College of Pharmacists (login required) or contact TPP directly at TPPinfo@cpsa.ab.ca or call 1 800 561 3899 ext. 4939.
Prescribers with TPP Prescribing Restrictions
CPSA can impose prescribing conditions on physicians that restrict their prescriptive authority under certain situations. These listings and conditions are shown below:
Surname | Given Name | Restrictions |
---|---|---|
Beeharry | Raj | Restricted from prescribing any benzodiazepines, including chloral hydrate, zopiclone and other z-drugs unless the prescription is: a. Prescribed as an anticonvulsant; b. Prescribed to a patient for a maximum of two weeks in any three month period; or c. Supported by written direction or recommendation from a consult from a specialist or knowledgeable colleague. Restricted from prescribing narcotic analgesics (or any products containing Codeine) unless the prescription is: a. A narcotic analgesic prescribed to a patient with malignancy-related pain that is documented by a pathology report or consultant’s report; b. A narcotic analgesic prescribed to a patient with acute, non-malignant pain for a maximum of two weeks for any three-month period; or c. Supported by written direction or recommendation from a consult from a specialist or knowledgeable colleague |
Collett | Franklin Dean | Prescribing restrictions apply. Prescribing restrictions for the following medications: Triplicate Prescription Program medications, anabolic steroids, methylphenidate, barbiturates, codeine containing drugs, amphetamine or amphetamine like appetite suppressants, benzodiazepines and other anxiolytics, hypnotics and sedatives, and muscle relaxants. |
Datar | Sunil | Shall not prescribe, dispense or provide samples of any drug that is listed on the College’s Triplicate Prescription Program Product List, whether prescribed using the triplicate pad or otherwise monitored by the program, inclusive of codeine products, benzodiazepines and “Z Class Drugs”. |
Gauri | Mohammed Ali | Restricted from prescribing triplicate prescriptions with the exception of opioid analgesics for malignancy-related pain documented by pathology report and/or consultant’s report. |
Iwashkiw | Boris Michael | Restricted from prescribing any drugs on the Triplicate Prescription Program (and no products containing Codeine) or any benzodiazepines and other anxiolytics, hypnotics and sedatives including Chloral Hydrate, Zopiclone or other Z-Drugs. |
Jabbari-Zadeh | Shahram | Restricted from prescribing tramadol containing medications, and any other medication on the Triplicate Prescription Program Medication List (Type 1 and Type 2 medications). | Jackman | Kevin F.M. | Restricted from prescribing any benzodiazepines and other anxiolytics, hypnotics and sedatives including chloral hydrate, zopiclone and other z-drugs with the following exceptions: prescribed as an anticonvulsant. Restricted from prescribing any drugs on the Triplicate Prescription Program Product List (and no products containing Codeine or tramadol) with the following exceptions: Narcotic analgesics for patients with malignancy-related pain that is documented by a pathology report or consultant’s report and non-TPP Narcotic analgesics (Codeine or Tramadol) for patients with acute non-malignant pain for a maximum of one week for each patient in any three month period. |
Krog | Pieter | Restricted from obtaining or using a triplicate prescription pad. |
Kordyban | Michael | Voluntarily surrenders all triplicate prescription pads under his control and shall not request resumption of prescribing of medications requiring the use of a triplicate prescription pad, in any manner. |
McAlpine | Brian Douglas | Restricted from prescribing triplicate medications.Restricted from prescribing stimulant medications or medications used in the treatment of Attention Deficit Disorder. |
McDonald | Norman | Prescribing restrictions apply. Not initiate to current patients prescriptions for benzodiazepines and other anxiolytics, hypnotics and sedatives including chloral hydrate, zopiclone and other z-drugs with the following exceptions: a. unless prescribed as an anticonvulsant; b. for a maximum period of two weeks for each patient in any three month period. Not initiate to current patients prescriptions for opioid analgesics, including Codeine with the following exceptions: a. for the management of cancer pain or palliative care; b. for a maximum of two weeks for each patient in any three month period. |
McPeak | Brian K. | Restricted from prescribing medications which require a triplicate prescription pad. |
Mohamed | Ataher S | Restricted from prescribing any medication monitored by the Triplicate Prescription Program. |
Moir | James Allan | Restricted from prescribing medications designated as part of the Triplicate Prescription Program. |
Neu | S. Randall | Restricted from prescribing triplicate medication. |
Rosenstock | Carl | Restricted from prescribing any benzodiazepines, including chloral hydrate, zopiclone and other z-drugs with the following exceptions: 1. Prescribed as an anticonvulsant; 2. Prescribed to a patient for a maximum of two weeks in any three month period; or 3. Supported by a direction or recommendation arising from a consult from a specialist or knowledgeable colleague. Restricted from prescribing any drugs on the Triplicate Prescription Program List (or any products containing Codeine) with the following exceptions: 1. A narcotic analgesic prescribed to a patient with malignancy-related pain that is documented by a pathology report or consultant’s report; 2. A narcotic analgesic prescribed to a patient with acute non-malignant pain for a maximum of two weeks for any three month period; or 3. Supported by a direction or recommendation arising from a consult from a specialist or knowledgeable colleague. |
Sheps | David M. | Restricted from prescribing Tramadol and any medications on the Triplicate Prescription Program medications list. |
Swart | Johan | Restricted from prescribing Tramadol products or medications on either of the schedules of the Triplicate Prescribing Program. |
Thompson | Robert Douglas | Restricted from prescribing any medications which require a Triplicate Prescription pad. |
White | Roger Tyler | Discontinue providing medications of potential abuse including triplicate program medications and benzodiazepines. |
Workun | Shane Alex | Triplicate prescriptions for in-patient hospital or long-term patient for a maximum of two weeks. |
FAQ
Eligible prescribers (physicians, podiatric physicians, nurse practitioners, dentists and veterinarians) may apply to the program by completing the Physician registration form or the Medical Residents registration form.
TPP Resources
- TPP Medication List
- Cannabis for Medical Purposes
- Sample Opioid Medication Treatment Agreement
- TPP Alberta – OME and DDD Conversion Factors
- TPP Atlas – The TPP Atlas provides an overview of provincial TPP medication utilization for the stated year.
- TPP Annual Report – The TPP annual report provides a comprehensive summary of program activities throughout the preceding year.
TPP News & Events
- MD Snapshot
- Access to valuable ADHD treatment now easier
- CAMH Opioid Dependence Treatment Course: For upcoming course dates, check the University of Calgary Cumming School of Medicine calendar
TPP Partners
TPP Alberta is funded primarily by the provincial government and administered by the CPSA. TPP partners:
WE CAN HELP
Physicians, pharmacists and other healthcare providers
Contact Triplicate Prescription Program
1-800-561-3899 (in Canada) ext. 4939
Patients
The College does not provide a list of physicians prescribing specific medications.
Other inquiries
Ed Jess, Director
Prescribing & Analytics
780-969-4946